Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study on Overall Survival and Quality of Life in Patients Older Than 60 Years With Acute Myeloid Leukemia Diagnosis in Spain, Treated According to Standard Clinical Practice

NCT03435341 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT03435341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03435341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study on Overall Survival and Quality of Life in Patients Older Than 60 Years With Acute Myeloid Leukemia Diagnosis in Spain, Treated According to Standard Clinical Practice
Lead sponsor
Celgene
Phase
Observational
Overall status
Completed
Start date
February 28, 2018
Completion date
April 30, 2020
Enrollment
151 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myeloid, acute